Treatment for chronic ischaemia-induced bladder detrusor dysfunction using bone marrow mesenchymal stem cells: an
Song Chen1, Hai-Yan Zhang, Ning Zhang
1Department of Urology, Beijing Chaoyang Hospital, Capital Medical University, Beijing 100020, P.R. China.
Bone marrow mesenchymal stem cells show promise in treating bladder dysfunction caused by chronic ischemia. This study found stem cell treatment improved bladder function and tissue health in an experimental model.
Area of Science:
- Regenerative Medicine
- Urology
- Stem Cell Biology
Background:
- Ischemia-induced bladder dysfunction is poorly understood, potentially involving M-receptor hypersensitivity, nerve injury, and fibrosis.
- Existing treatments for bladder ischemia's histological and functional changes are ineffective.
- Bladder outlet obstruction and aging are linked to chronic bladder ischemia.
Purpose of the Study:
- To evaluate the feasibility and effectiveness of bone marrow mesenchymal stem cells (BM-MSCs) for treating chronic ischemia-induced bladder detrusor dysfunction.
- To assess the impact of BM-MSCs on bladder function and histology in an experimental rat model.
Main Methods:
- BM-MSCs from Sprague-Dawley (SD) rats were injected into the common iliac artery, followed by iliac artery ligation and doxazosin mesylate administration.
- Urodynamic examinations and intravesical pressure measurements were conducted eight weeks post-treatment.
- Histological analysis included immunohistochemistry and trichrome staining to evaluate smooth muscle content and nerve fibers.
Main Results:
- Ischemic bladders showed significantly reduced intravesical pressure and detrusor contraction power compared to experimental and control groups.
- Stem cell treatment (experimental group) restored intravesical pressure and detrusor contraction power, showing no significant difference from the control group.
- Histology revealed increased smooth muscle content and nerve fibers in the experimental group compared to the ischemia group, with stem cell regeneration confirmed by BrdU staining.
Conclusions:
- Chronic bladder ischemia leads to decreased smooth muscle content, reduced nerve fibers, and impaired detrusor contractility.
- Intra-arterial BM-MSC injection combined with doxazosin mesylate promotes stem cell regeneration in ischemic bladder tissue.
- This treatment approach effectively improves bladder detrusor smooth muscle content, nerve regeneration, and overall bladder function.
More Related Videos
04:09Prospective, Randomized, and Controlled Study of a Human Umbilical Cord Mesenchymal Stem Cell Injection for Treating Diabetic Foot Ulcers
Published on: March 3, 2023
07:50Delayed Intramyocardial Delivery of Stem Cells after Ischemia Reperfusion Injury in a Murine Model
Published on: September 3, 2020
